期刊
JOURNAL OF LEUKOCYTE BIOLOGY
卷 89, 期 1, 页码 113-125出版社
WILEY
DOI: 10.1189/jlb.0410200
关键词
activation signaling; intracellular calcium
资金
- National Institutes of Health [P01 MH076388, R01 MH049981, U01 MH090325]
- NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH090325, P01MH076388, U01MH083545, R01MH049981] Funding Source: NIH RePORTER
SP is a potent neuroimmunomodulator that functions through ligating members of the neurokinin receptor family, one of which, NK1R, is widely expressed in immune cells. As in humans, circulating SP levels are increased in pathologic states associated with impairment of NK cell functions, such as depression and HIV infection, we hypothesized that SP has a direct, inhibitory effect upon NK cells. We have studied a clonal human NK cell line (YTS) as well as ex vivo human NK cells and have determined that truncated and full-length NK1R isoforms are expressed in and SP bound by ex vivo NK cells and the YTS NK cell line. Incubation of YTS cells with 10(-6) M SP and ex vivo NK cells with 10(-5) M SP inhibited cytotoxic ability by similar to 20% and reduced degranulation. This inhibitory effect upon cytotoxicity was partially prevented by the NK1R antagonist CP96,345. The treatment of YTS or ex vivo NK cells with SP neither down-modulated NCR expression nor affected triggering receptor-induced NF-kappa B activation. Preincubation of YTS cells with SP, however, did abbreviate the typically prolonged intracellular calcium increase induced by target cell engagement and reduced triggering receptor-induced pERK. Thus, SP has the potential to regulate NK cell functions and acts downstream from neurokinin receptors to modulate NK cell activation signaling. This mechanism may contribute to impairment of NK cell function in certain disease states associated with increased circulating SP. Antagonism of this system may present an opportunity to augment NK cell function therapeutically in selected human diseases. J. Leukoc. Biol. 89: 113-125; 2011.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据